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Abstract
Background and Objectives: Although primary care clinicians provide >60% of U.S. asthma 
care, no nationally representative study has examined variation in adherence among primary care 
groups to four cornerstone domains of the Expert Panel Report-3 asthma guidelines: assessment/
monitoring, patient education, environmental assessment, and medications. We used the 2012 
National Asthma Survey of Physicians: National Ambulatory Medical Care Survey to compare 
adherence by family/general medicine practitioners (FM/GM), internists, pediatricians and 
Community Health Center mid-level clinicians (CHC).
Methods: Adherence was self-reported (n=1,355 clinicians). Adjusted odds of almost always 
adhering to each recommendation (≥75% of the time) were estimated controlling for clinician/
practice characteristics, and agreement and self-efficacy with guideline recommendations.
Results: A higher percentage of pediatricians adhered to most assessment/monitoring 
recommendations compared to FM/GM and other groups (e.g., 71.6% [SE 4.0] almost always 
assessed daytime symptoms versus 50.6% [SE 5.1]-51.1% [SE 5.8], t-test P<.05) but low 
percentages from all groups almost always performed spirometry (6.8% [SE 2.0]-16.8% [SE 4.7]). 
Pediatricians were more likely to provide asthma action/treatment plans than FM/GM and 
internists. Internists were more likely to assess school/work triggers than pediatricians and CHC 
(environmental assessment). All groups prescribed inhaled corticosteroids for daily control (84.0% 
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[SE 3.7]-90.7% [SE 2.5]) (medications). In adjusted analyses, pediatric specialty, high self-
efficacy and frequent specialist referral were associated with high adherence.
Conclusions: Pediatricians were more likely to report high adherence than other clinicians. Self-
efficacy and frequent referral were also associated with adherence. Adherence was higher for 
history-taking recommendations and lower for recommendations involving patient education, 
equipment and expertise.
Introduction
Primary care clinicians are the front-line providers for US asthma patients. Of the 
approximately 15 million non-emergent ambulatory asthma visits made annually, over 60% 
occur in primary care settings.1,2 The Expert Panel Report-3 (EPR-3): Guidelines for the 
Diagnosis and Management of Asthma3 highlighted four evidence-based cornerstone 
components of asthma care: assessment/monitoring, patient education, control of 
environmental factors and pharmacologic treatment. Efforts to increase guideline 
implementation have ranged from public education campaigns4 to a guideline 
implementation report.5 Despite multifaceted efforts, clinician adherence to guideline 
recommendations has been low for many reasons (e.g., lack of self-efficacy and/or 
agreement with guidelines, guideline complexity, patient characteristics, organization 
barriers, reimbursement, and burnout).6–20 However, no previous study has compared 
similarities and differences in adherence between primary care groups for the four major 
components of the guidelines. A review found that a minority of studies involved pediatric 
health care providers and called for studies applicable across the health care provider 
spectrum.21 Understanding the variation and similarities in practice between guideline 
components and differential uptake between primary care provider groups can inform future 
interventions to increase implementation.
The 2012 National Asthma Survey of Physicians (NAS): National Ambulatory Medical Care 
Survey (NAMCS), a one-time provider questionnaire supplement to the National Center for 
Health Statistics’s (NCHS) NAMCS, was designed to assess clinician agreement, self-
efficacy (belief in one’s own ability to execute specific tasks to achieve performance goals) 
and adherence with EPR-3 recommendations among a nationally representative sample of 
clinicians. NAS data were released in 2017. A previous analysis of the NAS assessed 
differences in guideline adherence between primary care clinicians and asthma specialists.22 
This study focuses on assessing and comparing adherence to the four cornerstone 
components of the guidelines among 4 major primary care clinician groups: family/general 
medicine (FM/GM), internal medicine (IM), pediatrics, and Community Health Center 
(CHC) mid-level clinicians. We hypothesized that guideline adherence differed among 
primary care clinician groups and was associated with differences in clinician agreement 
with guideline recommendations and self-efficacy with performing guideline-based care.
7,8,14
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Methods
Data Source and Study Population
The annually-conducted NAMCS 23 provides nationally representative data about patient 
visit and provider characteristics and includes two sampling frames. The office-based frame 
includes non-federally employed physicians engaged in office-based patient care per the 
American Medical Association or the American Osteopathic Association. The Community 
Health Centers (CHC) frame includes physicians and mid-level practitioners (i.e., physician 
assistants, nurse practitioners, and nurse midwives) from sampled CHCs. The 2012 NAS 
was a one-time clinician questionnaire supplement to NAMCS and included clinicians in 
both NAMCS frames who responded affirmatively to: “Do you treat patients with 
asthma?”23,24 The NCHS Institutional Review Board approved the NAS and informed 
consent was obtained from participating clinicians.
The unweighted and weighted NAS response rates were 38% and 28%, respectively, similar 
to or higher than other national physician surveys.25 Demographic information included 
clinician age and sex. Clinician race/ethnicity and board certification were not available. 
Practice characteristics included census region, urbanization level, ownership, age of patient 
population, and asthma patient volume. Of the 1,726 respondents, 304 specialists were 
excluded as well as 67 primary care clinicians with missing information and those with non-
clinical roles (4.7% of primary care respondents). The final sample size was 1,355.
Guideline adherence, agreement and self-efficacy
Guideline recommendations were categorized into four components: assessment/monitoring, 
patient education, control of environmental factors, and pharmacologic treatment (see 
Supplemental Table E1). Self-reported adherence was evaluated by the percentage of asthma 
visits in which each recommendation was followed (“almost always”, ≥75%; “often”, 25–
74%; “sometimes”, 1–24%; “never”, 0%). The “sometimes” and “never” categories were 
combined due to low response frequencies. Clinicians were also asked about the frequency 
of patient concerns and confusion about medications. The results were dichotomized to 
“almost always/often” versus “sometimes/never” due to low frequencies of “almost always” 
responses. While these outcomes are not guideline recommendations, responses can be 
considered an indicator of perceived need for patient education.
To assess how adherence was associated with guideline agreement and self-efficacy, we 
constructed two dichotomous index variables (see Supplemental Table E2). The survey 
included five questions each on agreement and self-efficacy. In general, for each of the 
questions, nearly or more than half of clinicians either strongly agreed with the guideline 
recommendation (with the exception of provision of asthma action plans for which 31% 
strongly agreed) or reported that they were very confident at performing the 
recommendation (with the exception of using spirometry of which 37% reported being very 
confident). To construct an index that could meaningfully discern agreement or self-efficacy, 
we dichotomized between the top category and others. The agreement index variable was 
categorized as a clinician response of “strongly agree” versus all other responses (“agree,” 
“neutral,” “disagree” and “strongly disagree”) to all five questions about guideline 
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agreement. Similarly, the self-efficacy index variable was defined as “very confident” versus 
all other responses (“somewhat confident,” “not at all confident” and “NA/do not perform”) 
to all five self-efficacy questions.
Statistical Analysis
National estimates were calculated using NAS sample weights that accounted for the 
probability of selection and non-response. Standard error (SE) estimation accounted for the 
complex survey design. Analyses were conducted using SAS 9.4 (SAS Institute, Cary, NC) 
and SUDAAN 11.0 (Research Triangle Institute). A relative standard error >30% (SE/
estimate) indicates low precision. Differences between primary care clinician groups across 
response categories were assessed using chi-square tests. When chi-square testing indicated 
statistically significant differences across groups, t-tests were performed to test pairwise 
differences in the proportion reporting high adherence (“almost always” performing a 
recommendation), and in the reported use of a medication for a specific indication.
A separate logistic regression model was used for each recommendation to examine 
associations with guideline adherence. Outcome variables (adherence to each given 
recommendation) were dichotomized to “almost always” versus all other responses. Records 
with missing responses for the outcome (0.01%−2.0%) were excluded from each model. 26 
Multivariable models were constructed a priori and included the two index variables for 
agreement and self-efficacy. As a sensitivity analysis, agreement for individual guideline 
items was assessed in logistic regression analysis when the agreement question matched the 
guideline recommendation (spirometry and AAP provision). Additional covariates included 
clinician group, clinician age group (<40, 40–59, 60+ years), clinician sex, practice region 
(Northeast, Midwest, South, West), urbanicity (large metro, medium/small metro, non-
metro), and referral frequency to asthma specialists (almost always versus often/sometimes/
never). While recommendations about specialist referral are included in the EPR-3 
guidelines, it is one of many topics outside of the four cornerstones of management. We 
considered referral behavior as a proxy measure for clinician decision-making and patient 
population characteristics for which no data were available. A previous analysis of primary 
care providers showed that low rates of allergy testing referral were correlated with factors 
that indicate lack of familiarity with asthma or with the guidelines (low outpatient asthma 
volume, being a resident in training, low familiarity with specific guideline components).8 
Another past study showed that perceived indications for specialty referral did not align with 
guideline-recommended reasons for specialist referral, and that referral decisions (higher 
referral among family practice physicians) and clinical practice (higher likelihood of 
diagnostic testing by family practice physicians) differed between primary care groups.9 In a 
sensitivity analysis, responses to questions about patient concerns and confusion were 
included in the regression model for AAP provision. Average weekly asthma patient volume 
(2.5% missing) was excluded from final models due to lack of statistical significance and 
lack of confounding.
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Results
Participant and practice characteristics are shown in Table 1. Compared to physicians, CHC 
mid-level practitioners were younger, more likely to be female, and to practice in non-
metropolitan areas. Overall, there was low prevalence of strong agreement with the 
guidelines (11.6%) which was driven by low levels of strong agreement that asthma action 
plans are effective (29.6%) and that spirometry is essential for diagnosis (35.4%) versus 
higher prevalence of strong agreement about efficacy of ICS (48.1%), the need for 6-month 
follow up visits (48.5%) and the need to assess severity to determine initial treatment 
(50.1%) (Table E3). Pediatricians were more likely to report higher asthma patient volume. 
Referral frequency was similar between groups. However, agreement and self-efficacy with 
guideline recommendations differed between primary care groups. Lower percentages of 
FM/GM expressed strong overall agreement with the guidelines (7.7%) compared to 
internists and CHC mild-level providers (16.4% and 17.4%, respectively). FM/GM and 
internists were more likely to report high self-efficacy with guideline recommendations 
(20.0% and 35.8%, respectively) compared to 12.6% of pediatricians and 8.7% of CHC mid-
level providers. These differences stemmed from lower percentages of clinicians with high 
self-efficacy with spirometry among pediatricians (20.3%) and CHC mid-level providers 
(21.2%) versus 42.0% FM/GM and 51.8% internists (Table E3).
Guideline component 1: assessing/monitoring
Adherence to assessment/monitoring recommendations differed between primary care 
groups (Table 2). Pediatricians were generally more likely to report almost always asking 
about individual components of asthma control compared to each of the other primary care 
groups, including the ability to engage in normal activities, daytime symptoms and nighttime 
symptoms (63.1%−71.6% of pediatricians versus 42.6%−51.1% of other clinician groups). 
High adherence was lower among CHC midlevel providers compared to other groups for 
asking about patient perception of control. Low percentages of all primary care groups 
reported use of a control assessment tool (6.4%−20.6%). Pediatricians were more likely than 
FM/GM and internists to almost always ask about rescue inhaler use frequency. For the two 
recommendations involving assessing risk frequency, pediatricians reported higher rates of 
“almost always” asking about oral steroid use frequency and ED visit frequency than 
FM/GM and CHC midlevel providers. For recommendations involving objective assessment 
and monitoring, only 5.7% to 12.2% of clinicians reported almost always asking about peak 
flow results, and only 6.8% to 16.8% reported almost always performing spirometry in 
patients who were able to perform this test. More than half of clinicians almost always 
assessed daily controller use among patients with persistent asthma, but adherence with 
inhaler technique assessment ranged between 13.6% (FM/GM, internists) and 23.0% 
(pediatricians).
Adjusted odds ratios (AORs) of almost always adhering to these 13 assessment/monitoring 
recommendations are shown in Figure 1 for primary care group, frequency of patient referral 
to asthma specialists, guideline agreement, and self-efficacy (see Table E4 for additional 
covariates). Solid symbols denote AORs with 95% confidence intervals that exclude 1.0. 
Pediatricians’ higher reported adherence was still apparent after controlling for covariates 
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(first vertical panel). Clinicians who reported almost always referring asthma patients for 
specialty care had higher odds of high adherence to several recommendations (second 
panel). Strong agreement with guideline recommendations was significantly associated with 
high adherence only to asking about rescue medication use frequency (third panel). In a 
sensitivity analysis of spirometry performance, strong agreement with spirometry 
recommendations in particular was analyzed in place of the overall agreement index and was 
found to be associated with high adherence to spirometry (AOR 3.6, 95%CI 1.6, 7.8) while 
results for the remaining covariates did not vary significantly from the main model (data not 
shown). High self-efficacy was associated with higher odds of high adherence to all 13 
recommendations (fourth panel). In general, clinician age group, sex, and practice location 
were not associated with higher guideline adherence (Table E4).
Guideline component 2: Patient education
Higher percentages of pediatricians reported almost always providing an AAP, (26.8%, SE 
3.6) compared to FM/GM (11.9%, SE 2.4) and internists (10.1%, SE 3.2). CHC mid-level 
clinicians had adherence similar to pediatricians, (20.3%, SE 4.3) but a pairwise comparison 
was not significant (data not shown). Pediatrics, frequent specialist referral and high self-
efficacy, but not strong agreement, were associated with higher adjusted odds of almost 
always providing an AAP (Figure 2 top panel). In a sensitivity analysis, we replaced the 
overall agreement index in the model with strong agreement with AAP recommendations, 
and found an association with high adherence to AAP provision (AOR 2.8, 95% CI 1.6, 4.8). 
The results for the remaining covariates did not vary significantly from the main model (data 
not shown).
Clinicians in all groups reported encountering patient misunderstanding, concerns, and 
confusion (Figure 3). There was group variation, however, with responses ranging from 
about 35% reporting misunderstanding “almost always” or “often” (FM/GM and IM) to 
~50% (pediatricians and CHC mid-level clinicians). Pediatricians more often reported 
patient/parental concern about long-term side effects of ICS compared to FM/GM or 
internists. More than half of FM/GM (60.5%), pediatricians (69.0%), and CHC mid-level 
providers (80.2%) reported that patients/parents were “often” or “almost always” confused 
about differences between rescue and control medications. In an additional sensitivity 
analysis, responses of patient medication concerns and confusion were included as 
covariates in the AAP provision logistic regression model. Only almost always/often 
encountering patient confusion between relief and controller medications approached a 
significant association with high adherence with AAP provision (AOR 1.8, 95% CI, 1.0, 3.2) 
and results for remaining covariates remained similar to those from the main model (data not 
shown).
Guideline component 3: assess and control environmental factors
There was no significant difference between primary care groups in reported adherence to 
assessing asthma triggers in the home (Table 3). However, internists were more likely than 
pediatricians or CHC midlevel providers to almost always assess asthma triggers in the 
school or workplace. Most primary care clinicians did not routinely test for allergic 
sensitivity.
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Figure 2 shows AORs for “almost always” adhering to environmental recommendations 
(bottom three rows, see Table E5 for remaining covariates). A high frequency of specialist 
referral and high self-efficacy were associated with greater odds of assessing environmental 
factors. For example, clinicians who reported “almost always” referring patients to asthma 
specialists had an AOR of 3.6 (95% CI 1.4, 9.6) of assessing school/workplace triggers 
compared to those never or sometimes referred patients, and those with high self-efficacy 
had an AOR of 3.8 (95% CI 2.2, 6.8) compared to those with lower than high self-efficacy. 
There was no significant association between primary care group and high adherence with 
assessing school/workplace triggers in adjusted analyses.
Guideline component 4: pharmacologic treatment
Asthma medication prescription generally followed guideline recommended indications 
(Figure 4). ICS were prescribed for daily long-term control by 84.0% or higher among all 
clinician groups. Short and long course oral steroids were prescribed predominantly for 
acute exacerbations and difficult to control asthma, respectively. Pediatricians were less 
likely to use long course oral steroids than other groups. Omalizumab and methylxanthines 
were rarely used for difficult to control asthma among all groups, and pediatricians were 
more likely to report never using these medications compared to other groups. 
Anticholinergics were used for all indications, but less frequently by pediatricians for daily 
long-term control and add-on daily control therapy. Pediatricians were more likely to report 
never using LABA and LABA/ICS combinations compared to each of the other clinician 
groups, and CHC midlevel providers were more likely to never use these medications 
compared to internists. Nearly all clinicians reported prescribing short acting beta agonists 
for acute exacerbations.
Discussion
Implementation of the EPR-3 guidelines is a healthcare and public health priority.5,27 
Adherence by primary care clinicians is particularly important because they manage the 
majority of asthma visits,1,2 and guideline utilization improves asthma outcomes.28–31 A 
previous analysis demonstrated that adherence and self-efficacy were higher among asthma 
specialists compared to primary care clinicians but did not assess differences among 
different primary care clinician groups.22 Higher percentages of pediatricians reported high 
adherence with assessment/monitoring and asthma action plan recommendations, but were 
less likely to use controller medications other than inhaled corticosteroids. Similarities 
between groups were also observed. More than half of FM/GM, pediatricians and CHC mid-
level providers reported patient confusion between rescue and control medications. Among 
all primary care groups, adherence was higher for recommendations involving history taking 
compared to those requiring iterative evaluation and objective assessment. Similar patterns 
of lower adherence for more resource-intensive recommendations have been observed in 
previous studies.7–9,11–20 Adherence was associated with high self-efficacy and frequent 
referral to asthma specialists. However, adherence was generally not associated with level of 
overall agreement with the guidelines which was low for all primary care groups. The index 
measure of agreement used in this study established a high threshold in that it required 
strong agreement with all five components assessed. It is likely that the association between 
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agreement and adherence is more nuanced: as seen for AAP provision and spirometry, 
agreement with those specific guideline recommendations is associated with adherence to 
those items. Thus, providing evidence of efficacy for key guideline recommendations to 
clinicians and facilitating implementation (e.g., time, reimbursement) may be important to 
increasing adherence, especially for resource intensive items. While the findings highlight 
challenges, national-level data provide helpful information for ongoing efforts to improve 
guideline adherence and areas for additional research.
Over 50% of clinicians reported almost always adhering to specific assessment/monitoring 
recommendations involving history taking. Cabana et al. demonstrated that vague, global 
assessment of asthma control led to overestimation of good control, and concluded that 
assessing specific individual components is necessary to determine control status and the 
appropriate level of therapy.32 Pediatricians were generally more likely to report almost 
always adhering to individual assessment/monitoring recommendations, but they were not 
more likely to report strong agreement or high self-efficacy with guideline 
recommendations. However, asthma prevalence is higher in children than adults, and asthma 
is one of the most common chronic childhood conditions. Of visits to primary care 
clinicians, the majority are likely to be made to pediatricians,33 and in the NAS, 
pediatricians reported the highest asthma patient volume. Yet, patient volume may be only 
part of the difference between primary care groups—there are also fewer chronic diseases 
among children demanding clinician attention. Clinicians treating adults face a much larger 
number of chronic conditions with coinciding guidelines and comorbidities. Thus, clinicians 
who primarily treat children may be more familiar with asthma guideline-based management 
because asthma is one of the major chronic conditions they encounter.
Low adherence was observed for provision of written AAPs, agreeing with previous studies.
5,8,9,12,13,15
 AAPs are as much a clinician care coordination tool as a patient education tool
—triggers, symptoms, and medication choice/dosage must all be understood and formulated 
to complete an AAP.5 AAPs are correlated with increased follow-up after emergency care, 
28,34
 adherence to preventive medication,28 and lower adverse outcomes,35 although others 
have questioned their added effectiveness in children who received other asthma education.
36
 High adherence to AAP provision was more likely among pediatricians, clinicians with 
frequent patient referrals to specialists, and those with high self-efficacy. A sensitivity 
analysis showed a significant association between AAP provision and agreement with this 
specific recommendation. Another sensitivity analysis showed that among patient concerns 
and confusions encountered, only confusion between rescue and controller medications was 
associated with AAP provision. It is unknown if encountering confusion spurred provision 
of an AAP, if such confusion was more likely to be uncovered when providing AAPs to 
patients, or both.
All clinician groups reported lower rates of high adherence with peak flow monitoring, 
spirometry and assessment of inhaler technique. These items involve assessment beyond 
history taking and/or require equipment that may be unavailable in a primary care setting. 
Similar patterns of lower adherence for more resource-intensive recommendations have been 
observed.7–9,11–20 Nevertheless, the feasibility of completing moderate-to-high levels of 
technical adequacy and accurate interpretation of spirometry in family medicine settings has 
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previously been demonstrated,37 and the importance of objective monitoring in the diagnosis 
and management of asthma in primary care continues to be affirmed.14,38 Despite feasibility, 
studies report providers citing lack of training and expertise in performing and interpreting 
spirometry as barriers,14,16,39 and thus self-efficacy could be an important barrier to 
spirometry in particular. In addition, our sensitivity analysis showed that strong agreement 
with the necessity of spirometry was associated with adherence to spirometry 
recommendations. A nationally representative study reported that a high percentage of 
clinicians ever used spirometry (68% primary care physicians and 88% specialists).15 These 
much higher percentages compared to NAS are likely due to questionnaire differences—the 
NAS asked clinicians in what percentage of asthma visits they performed recommended 
guideline actions, a more narrow scope than “ever” using these tools. The EPR-3 guidelines 
recommend spirometry at least every 1–2 years, during periods of loss of asthma control, 
and as indicated by clinical severity.3 However, even considering this periodic recommended 
use, less than half of NAS respondents reported using spirometry >25% of the time.
ICS prescription for long-term asthma control is a key recommendation (84% or higher 
among all groups used ICS for daily long-term control). Previous studies reported 62–70% 
of clinicians regularly prescribed ICS but did not directly assess clinical indications.8,19 
Previous studies reported concerns about ICS side effects9 and low adherence among 
primary care providers versus specialists.15,40 Sustained efforts to increase ICS use5 may 
have addressed barriers and concerns. Pediatricians and CHC mid-level providers were more 
likely to report never using other controller medications (long course oral steroids, 
omalizumab, methylxanthines, anticholinergics and LABA). Although a 2010 Food and 
Drug Administration statement recommended LABA use only in combination with ICS and 
efficacy and safety of LABA/ICS therapy in children has been demonstrated,41 safety 
concerns at the time of the survey could have resulted in avoidance of LABA in any form 
among clinicians treating children.
High self-efficacy with guideline recommendations and frequent patient referral to asthma 
specialists were associated with guideline adherence, but while high self-efficacy differed 
between clinician groups, it did not completely explain differences in adherence. 
Pediatricians had lower self-efficacy compared to internal medicine and family/general 
medicine clinicians despite the higher rate of adherence. Focusing guideline implementation 
efforts on self-efficacy could potentially improve adherence across all groups, but perhaps 
not address the differences in uptake of guideline recommendations between primary care 
clinician groups. Self-efficacy—confidence in implementing a goal-directed behavior—has 
been hypothesized to increase adherence 6,7,39 but may not be sufficient.6 A study of 
primary care physician adherence with COPD spirometry recommendations found low 
adherence despite high agreement and self-efficacy.39 A major barrier was lack of onsite 
equipment. Another study of asthma guidelines found that self-efficacy was necessary but 
not sufficient to increase guideline implementation.6 It is likely that observed associations 
with self-efficacy are sensitive to the measurement of this concept and that heterogeneity in 
the findings of the impact of perceived confidence should be expected. Referral behavior 
likely has a complex association with guideline adherence. EPR-3 guidelines recommend 
referral for life-threatening exacerbations, difficult to control asthma, atypical signs/
symptoms or uncertain diagnosis, and high risk (oral steroids or hospitalization).3 Studies 
Akinbami et al. Page 9
J Asthma. Author manuscript; available in PMC 2020 September 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
have reported high referral rates for life-threatening asthma events (>90%), whereas referral 
rates for other types of high-risk patients, including those with difficult to control asthma 
and uncertain diagnosis, have been lower (40–50%).9,12 Another aspect of referral behavior 
is the clinician’s patient population profile. One study found that lower outpatient asthma 
volume was associated with lower rates of allergy testing referral.8 Furthermore, low access 
to specialists has been associated with low income and may be an indicator of health care 
resources and quality.42
The NAS provided nationally representative data on the four EPR-3 cornerstone components 
with sufficient sample size, and thus allowed comparison of primary care clinician groups. 
Nevertheless, clinician self-report of adherence is a limitation and raises the possibility of 
recall bias and social desirability bias. While high adherence rates in this study to 
medications and environmental assessment were similar to those in a study assessing 
adherence using medical records,19 adherence to other items such as AAP provision were 
higher in this study, suggesting possible over-reporting. Nevertheless, the general 
magnitudes of adherence were similar (i.e., highest for medications, lower for items 
requiring documentation and patient education). The NAS did not collect visit-level data and 
patient characteristics such as age, race/ethnicity or disease severity. The NAS was not 
designed to assess other aspects of care, such as criteria for referral or patient population 
characteristics (e.g., asthma severity). In addition, the NAS included clinicians treating 
pediatric and adult populations. Other researchers have noted that pediatric healthcare 
involves aspects different than adult care, including a different natural history of asthma and 
caregiver structure. However, they conclude that the EPR-3 guidelines provide uniform 
cornerstone recommendations for patients of all ages.21 Detailed probing of familiarity, 
ambivalence and outcome expectancy with EPR-3 recommendations was not included in the 
NAS. Previous studies found high awareness of the asthma guidelines,7–9 although 
familiarity with specific recommendations was lower.8
Conclusions
Variation in implementation of recommended asthma care exists between primary care 
groups. High adherence was more likely to be reported by pediatricians for assessment/
monitoring and patient education. There was no difference between clinician groups with 
high adherence to environmental assessment and medication prescription for acute 
exacerbations and long-term control. This survey also demonstrated higher adherence to 
guideline recommendations among all groups that could be considered “low hanging fruit”
—those involving history taking. Recommendations requiring additional equipment, training 
and patient education had lower rates of high adherence. Future research could examine 
interventions to enhance adherence to resource-intensive recommendations, the potentially 
nuanced role of self-efficacy, and clinical decision-making underlying referral behavior.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Abbreviations:
AAP Asthma Action Plan
CHC Community Health Center
EPR-3 Expert Panel Report-3
FM/GM family/general medicine
ICS Inhaled corticosteroids
IM internal medicine
LABA Long acting beta agonist
NAMCS National Ambulatory Medical Care Survey
NAS National Asthma Survey of Physicians
RSE relative standard error
SE standard error
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Figure 1. 
Adjusted OR, 95%CI of “almost always” adhering to assessment and monitoring 
recommendations, Guideline component 1
Notes: Solid symbols denote AOR with 95% confidence interval excluding 1.0. AORs are on 
the logarithmic scale with a, maximum value of 20. Confidence intervals ending with an 
open arrow denote confidence limits that exceed the scale, Source: 2012 National Asthma 
Survey of Physicians: National Ambulatory Medical Care Survey
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Figure 2. 
Adjusted odds of reported adherence to 4 guideline recommendations for environmental 
assessment, by specialist referral frequency, perceived, competency with guidelines, 
agreement with guidelines and primary care specialty, National Asthma Survey of 
Physicians
Notes: Solid symbols denote AORs with 95% confidence interval excluding 1.0. The AORs 
are on the logarithmic scale with a maximum value, of 40. Confidence intervals with open 
an arrow denote confidence limits that exceed the scale.
See Table E5 for results for additional covariates.
Source: 2012 National Asthma Survey of Physicians: National Ambulatory Medical Care 
Survey
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Figure 3. 
Percent of primary care clinicians who reported patient misunderstanding and concerns 
about asthma medications: Guideline, component 2
* Statistically significant difference between primary care specialty groups.
† Relative standard error >30%
a
 Significantly higher compared to all other clinician groups (t‐test p‐value<.05)
Notes: Adherence categories: Adherence categories: Almost always (>75% of the time), 
Often (25‐<75%), Sometimes/Never (<25% of the time)
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Figure 4: 
Reported use of medication by indication, by primary care group: Guideline component 4
* Statistically significant difference between primary care specialty group
Source: National Asthma Survey of Physicians: National Ambulatory Medical Care Survey
Akinbami et al. Page 17
J Asthma. Author manuscript; available in PMC 2020 September 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Akinbami et al. Page 18
Table 1:
Characteristics of Primary Care Clinicians, 2012 National Asthma Survey of Physicians (weighted %, SE)
n Total
Family/General
Medicine
(n=524)
Internal
Medicine
(n=196)
Pediatrics
(n=302)
CHC Mid-
level
Clinicians
(n=333)
Chi-
square
p-
value
Total 1355 100 (0.0) 40.4 (2.2) 26.0 (2.4) 24.6 (1.9) 9.0 (0.6)
Provider age (years)a
  <40 334 16.2 (1.5) 14.4 (2.3) 7.6 (2.9)† 18.1 (3.2) 44.2 (5.0) <.001
  40–59 748 59.9 (2.3) 57.2 (3.5) 69.6 (5.3) 60.5 (4.2) 42.7 (4.4)
  60+ 273 23.9 (2.1) 28.5 (3.3) 22.8 (4.8) 21.4 (3.6) 13.1 (2.7)
Provider sexa,b
  Female 700 41.8 (2.2) 35.4 (3.4) 28.4 (4.6) 51.6 (4.2) 83.5 (2.8) <.001
  Male 655 58.2 (2.2) 64.6 (3.4) 71.6 (4.6) 48.4 (4.2) 16.5 (2.8)
Census region
  Northeast 192 20.0 (1.0) 16.4 (2.6) 23.0 (4.1) 24.1 (2.8) 16.3 (2.7) .110
  Midwest 338 19.9 (0.8) 25.1 (2.2) 15.9 (3.2) 15.9 (2.1) 18.9 (2.4)
  South 463 30.2 (1.0) 27.3 (2.4) 30.7 (4.3) 36.2 (3.5) 25.2 (2.6)
  West 362 29.9 (1.1) 31.2 (2.9) 30.4 (5.4) 23.8 (3.8) 39.6 (3.7)
Level of urbanizationa,c
  Large Metro 562 56.2 (2.1) 49.3 (3.2) 68.9 (4.8) 61.0 (4.1) 39.4 (5.1) <.001
  Medium/Small Metro 443 29.0 (2.0) 30.6 (2.9) 22.8 (4.5) 29.9 (3.9) 34.3 (5.2)
  Non-metro 350 14.8 (1.2) 20.1 (2.4) 8.3 (2.1) 9.2 (2.0) 26.3 (3.7)
Asthma patient volumed (#/week)
  <3 267 20.7 (2.0) 22.4 (2.9) 31.7 (5.5) 7.8 (1.7) 16.5 (3.1) <.001
  3–12 740 48.3 (2.2) 52.3 (3.6) 41.8 (5.1) 48.0 (4.2) 49.9 (4.3)
  13+ 241 19.3 (1.9) 14.9 (2.6) 10.4 (3.5)† 34.7 (4.3) 22.9 (4.6)
  missing 107 11.7 (1.8) 10.5 (2.6) 16.1 (5.0)† 9.6 (3.0)† 10.7 (3.6)†
Referral frequency to specialist
  Always (>75% of time) 90 8.0 (1.4) 6.1 (1.6) 12.1 (4.1)† 7.5 (2.5)† 6.3 (2.2)† .370
  Often (25-<75% of time) 387 29.5 (2.1) 25.9 (3.0) 30.0 (5.3) 34.1 (4.0) 31.5 (4.6)
  Sometimes/never (<25%) 878 62.5 (2.3) 68.0 (3.2) 57.9 (5.7) 58.4 (4.2) 62.2 (4.8)
Agreement indexe
  Strongly agree 179 11.6 (1.4) 7.7 (1.4) 16.4 (3.8) 10.8 (2.7) 17.4 (3.8) .050
  All other responses 1176 88.4 (1.6) 92.3 (1.4) 83.6 (3.8) 89.2 (2.7) 82.6 (3.8)
Self-efficacy indexc,f
  Very confident 261 21.3 (2.2) 20.0 (2.8) 35.8 (5.8) 12.6 (2.5) 8.7 (2.3) <.001
  All other responses 1094 78.7 (2.2) 80.0 (2.8) 64.2 (5.8) 87.4 (2.5) 91.3 (2.3)
†
Relative standard error >30%
Notes: CHC: Community Health Center; SE: standard error
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Source: National Center for Health Statistics, 2012 National Asthma Survey of Physicians: National Ambulatory Medical Care Survey
aCHC significantly different than all other categories, t-test P<.05
b
Pediatrics significantly different than all other categories, t-test P<.05
c
FM/GM significantly different than all other categories, t-test P<.05
d
Pediatrics significantly different than FM/GM, internists, t-test P<.05
e
FM/GM significantly different than internists, CHC, t-test P<.05
f
Internists significantly different than all other categories, t-test P<.05
J Asthma. Author manuscript; available in PMC 2020 September 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Akinbami et al. Page 20
Ta
bl
e 
2:
Pe
rc
en
t o
f p
rim
ar
y 
ca
re
 c
lin
ic
ia
ns
 re
po
rti
ng
 a
ss
es
sin
g/
m
on
ito
rin
g 
as
th
m
a 
se
v
er
ity
 &
 c
on
tro
l: 
G
ui
de
lin
e 
co
m
po
ne
nt
 1
Fa
m
ily
/G
en
er
al
 M
ed
ic
in
e
In
te
rn
a
l M
ed
ic
in
e
Pe
di
at
ri
cs
C
H
C
 M
id
-le
v
el
 C
lin
ic
ia
ns
n
A
lm
os
t
a
lw
ay
s
O
fte
n
So
m
et
i
m
es
/
N
ev
er
A
lm
os
t
a
lw
ay
s
O
fte
n
So
m
et
i
m
es
/N
ev
er
A
lm
os
t
a
lw
ay
s
O
fte
n
So
m
et
i
m
es
/
N
ev
er
A
lm
os
t
a
lw
ay
s
O
fte
n
So
m
et
i
m
es
/
N
ev
er
C
hi
-
sq
ua
re
p-
va
lu
e
A
ss
es
sm
en
t o
f i
m
pa
ir
m
en
t f
re
qu
en
cy
,
 
w
ei
gh
te
d 
%
 (S
E)
D
oc
um
en
t 
as
th
m
a 
co
nt
ro
l
12
76
31
.7
 (3
.5)
43
.1
 
(3.
5)
25
.2
 (3
.3)
27
.1
 (4
.7)
50
.4
 
(5.
9)
22
.5
 (5
.2)
37
.2
 (4
.2)
43
.8
 
(4.
4)
19
.0
 (3
.6)
34
.5
 (5
.1)
36
.9
 
(4.
8)
28
.5
 (4
.3)
0.
47
A
sk
 a
bo
ut
 
ab
ili
ty
 e
ng
ag
e 
in
 n
or
m
al
 
ac
tiv
iti
es
13
43
42
.6
 (3
.5)
42
.2
 
(3.
5)
15
.2
 (2
.8)
43
.2
 (5
.8)
44
.4
 
(5.
6)
12
.4
 (3
.2)
63
.1
a  
(4.
1)
29
.5
 
(3.
9)
7.
4 
(1.
8)
43
.5
 (4
.7)
36
.6
 
(4.
5)
19
.9
 (4
.1)
0.
00
6
A
sk
 a
bo
ut
 
fre
qu
en
cy
 o
f 
da
yt
im
e 
sy
m
pt
om
s
13
48
50
.6
 (3
.4)
42
.9
 
(3.
6)
6.
5 
(1.
9)
51
.1
 (5
.8)
38
.9
 
(5.
6)
10
.1
 (3
.0)
71
.6
a  
(4.
0)
23
.0
 
(3.
7)
5.
4†
 
(2.
2)
50
.6
 (5
.1)
36
.0
 
(4.
5)
13
.4
 (3
.6)
0.
00
4
A
sk
 a
bo
ut
 
fre
qu
en
cy
 o
f 
n
ig
ht
tim
e 
aw
ak
en
in
g
13
46
47
.8
 (3
.6)
36
.6
 
(3.
5)
15
.7
 (2
.8)
47
.2
 (5
.8)
31
.0
 
(5.
0)
21
.9
 (4
.8)
70
.0
a  
(4.
0)
25
.7
 
(3.
9)
4.
3 
(1.
4)
49
.6
 (4
.8)
32
.7
 
(4.
5)
17
.7
 (3
.8)
<
0.
00
1
A
sk
 a
bo
ut
 
pe
rc
ep
tio
n 
of
 
co
n
tr
ol
13
44
54
.4
 (3
.6)
31
.8
 
(3.
2)
13
.8
 (2
.9)
43
.9
 (5
.7)
42
.2
 
(5.
6)
14
.0
 (4
.1)
55
.8
 (4
.3)
23
.7
 
(3.
2)
20
.5
 (3
.8)
33
.9
b  
(4.
5)
42
.2
 
(4.
5)
23
.9
 (4
.2)
0.
01
6
U
se
 c
on
tro
l 
as
se
ss
m
en
t t
oo
l
13
44
12
.1
 (2
.4)
13
.3
 
(2.
5)
74
.5
 (3
.2)
6.
4†
 
(2.
1)
20
.6
 
(5.
0)
73
.0
 (5
.2)
20
.6
a  
(3.
5)
18
.1
 
(3.
3)
61
.3
 (4
.2)
13
.0
 (3
.9)
13
.0
 
(2.
9)
74
.0
 (4
.4)
0.
02
1
A
sk
 a
bo
ut
 
fre
qu
en
cy
 
re
sc
u
e 
in
ha
le
r
13
47
69
.8
 (3
.4)
28
.0
 
(3.
4)
2.
2†
 
(1.
0)
67
.4
 (5
.1)
23
.0
 
(4.
3)
9.
6†
 
(3.
5)
81
.4
c  
(3.
1)
18
.0
 
(3.
1)
0.
7†
 
(0.
4)
71
.5
 (4
.5)
21
.9
 
(3.
8)
6.
6†
 
(3.
2)
0.
01
1
A
ss
es
sm
en
t o
f r
isk
 fr
eq
ue
nc
y,
 
w
ei
gh
te
d 
%
 (S
E)
A
sk
 a
bo
ut
 o
ra
l 
st
er
oi
d 
fre
qu
en
cy
13
47
49
.1
 (3
.6)
35
.7
 
(3.
4)
15
.3
 (2
.9)
52
.2
 (5
.7)
36
.6
 
(5.
2)
11
.2
† 
(3.
6)
65
.9
d  
(4.
2)
28
.2
 
(3.
9)
6.
0†
 
(2.
3)
38
.4
 (4
.7)
39
.3
 
(4.
7)
22
.3
 (4
.3)
0.
01
0
A
sk
 a
bo
ut
 E
D
 
v
isi
t f
re
qu
en
cy
13
48
50
.2
 (3
.6)
29
.0
 
(3.
1)
20
.8
 (3
.3)
57
.8
 (5
.4)
33
.7
 
(5.
0)
8.
5†
 
(2.
8)
65
.4
d  
(4.
2)
27
.2
 
(3.
9)
7.
4†
 
(2.
7)
47
.4
 (4
.9)
30
.5
 
(4.
1)
22
.1
 (4
.5)
0.
00
4
O
bje
cti
v
e 
a
ss
es
sm
en
t a
nd
 m
on
ito
ri
ng
,
 
w
ei
gh
te
d 
%
 (S
E)
A
sk
 a
bo
ut
 p
ea
k 
flo
w
 r
es
u
lts
13
46
8.
6 
(1.
9)
27
.5
 
(3.
2)
64
.0
 (3
.4)
10
.4
†  (
3.4
)
30
.7
 
(5.
4)
58
.9
 (5
.7)
12
.2
 (2
.6)
13
.6
 
(2.
4)
74
.2
 (3
.3)
5.
7†
 
(2.
3)
10
.7
 
(2.
8)
83
.6
 (3
.5)
0.
00
2
Pe
rfo
rm
 
sp
iro
m
et
ry
13
30
6.
8 
(2.
0)
25
.4
 
(2.
8)
67
.8
 (3
.2)
16
.8
 (4
.7)
30
.8
 
(5.
2)
52
.4
 (5
.7)
10
.0
 (2
.2)
20
.6
 
(3.
5)
69
.4
 (3
.9)
8.
1†
 
(2.
5)
16
.3
 
(3.
2)
75
.5
 (3
.8)
0.
02
5
J Asthma. Author manuscript; available in PMC 2020 September 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Akinbami et al. Page 21
Fa
m
ily
/G
en
er
al
 M
ed
ic
in
e
In
te
rn
a
l M
ed
ic
in
e
Pe
di
at
ri
cs
C
H
C
 M
id
-le
v
el
 C
lin
ic
ia
ns
n
A
lm
os
t
a
lw
ay
s
O
fte
n
So
m
et
i
m
es
/
N
ev
er
A
lm
os
t
a
lw
ay
s
O
fte
n
So
m
et
i
m
es
/N
ev
er
A
lm
os
t
a
lw
ay
s
O
fte
n
So
m
et
i
m
es
/
N
ev
er
A
lm
os
t
a
lw
ay
s
O
fte
n
So
m
et
i
m
es
/
N
ev
er
C
hi
-
sq
ua
re
p-
va
lu
e
O
ng
oi
ng
 m
on
ito
ri
ng
 fr
eq
ue
nc
y,
 
w
ei
gh
te
d 
%
 (S
E)
A
ss
es
s d
ai
ly
 
co
n
tr
ol
le
r u
se
 
pe
rs
ist
en
t 
as
th
m
a
13
48
60
.1
 (3
.5)
33
.3
 
(3.
4)
6.
6 
(1.
6)
56
.8
 (5
.6)
29
.2
 
(4.
9)
14
.0
† 
(4.
2)
61
.3
 (4
.4)
34
.3
 
(4.
3)
4.
5†
 
(1.
8)
59
.8
 (4
.9)
29
.0
 
(4.
1)
11
.2
† 
(3.
5)
0.
25
R
ep
ea
te
d 
as
se
ss
m
en
t o
f 
in
ha
le
r 
te
ch
ni
qu
e
13
49
13
.6
 (2
.5)
36
.2
 
(3.
5)
50
.3
 (3
.6)
13
.6
 (3
.5)
41
.2
 
(5.
7)
45
.2
 (5
.5)
23
.0
e  
(3.
4)
41
.4
 
(4.
3)
35
.6
 (4
.1)
17
.2
 (4
.6)
36
.5
 
(4.
8)
46
.3
 (5
.2)
0.
18
† R
el
at
iv
e 
st
an
da
rd
 e
rro
r >
30
%
a S
ig
ni
fic
an
tly
 h
ig
he
r c
om
pa
re
d 
to
 o
th
er
 c
lin
ic
ia
n 
gr
ou
ps
 (t
-te
st 
p-v
al
ue
 <
.0
5)
b S
ig
ni
fic
an
tly
 lo
w
er
 c
o
m
pa
re
d 
to
 F
M
/G
M
 a
nd
 p
ed
ia
tri
cs
 (t
-te
st 
p-v
al
ue
<.
05
)
c S
ig
ni
fic
an
tly
 h
ig
he
r c
om
pa
re
d 
to
 F
M
/G
M
 a
nd
 in
te
rn
ist
s (
t-t
est
 p-
va
lu
e 
<.
05
)
d S
ig
ni
fic
an
tly
 h
ig
he
r c
om
pa
re
d 
to
 F
M
/G
M
 a
nd
 C
H
C 
(t-
tes
t p
-va
lu
e 
<.
05
)
e S
ig
ni
fic
an
tly
 h
ig
he
r c
om
pa
re
d 
to
 F
M
/G
M
 (t
-te
st 
p-v
al
ue
 <
.0
5)
N
ot
es
: A
dh
er
en
ce
 c
at
eg
or
ie
s: 
A
lm
os
t a
lw
ay
s (
≥7
5%
 of
 th
e t
im
e),
 O
fte
n (
25
-<
75
%)
, S
om
eti
me
s (
1–
24
%)
, N
ev
er
 (0
%)
; C
HC
: C
om
mu
nit
y H
ea
lth
 C
en
ter
; E
D:
 em
erg
en
cy
 d
ep
ar
tm
en
t; 
SE
: s
ta
nd
ar
d 
er
ro
r
So
ur
ce
: N
at
io
na
l C
en
te
r f
or
 H
ea
lth
 S
ta
tis
tic
s, 
20
12
 N
at
io
na
l A
sth
m
a 
Su
rv
ey
 o
f P
hy
sic
ia
ns
: N
at
io
na
l A
m
bu
la
to
ry
 M
ed
ic
al
 C
ar
e 
Su
rv
ey
J Asthma. Author manuscript; available in PMC 2020 September 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Akinbami et al. Page 22
Ta
bl
e 
3.
A
dh
er
en
ce
 w
ith
 g
ui
de
lin
e-
re
co
m
m
en
de
d 
m
ea
su
re
s t
o 
as
se
ss
 e
nv
iro
nm
en
ta
l f
ac
to
rs
: G
ui
de
lin
e 
co
m
po
ne
nt
 3
 (w
eig
hte
d %
, S
E)
Fa
m
ily
/G
en
er
al
 M
ed
ic
in
e
In
te
rn
a
l M
ed
ic
in
e
Pe
di
at
ri
cs
C
H
C
 M
id
-le
v
el
 C
lin
ic
ia
ns
n
A
lm
os
t
a
lw
ay
s
O
fte
n
So
m
et
i
m
es
/
N
ev
er
A
lm
os
t
a
lw
ay
s
O
fte
n
So
m
et
i
m
es
/N
ev
er
A
lm
os
t
a
lw
ay
s
O
fte
n
So
m
et
i
m
es
/
N
ev
er
A
lm
os
t
a
lw
ay
s
O
fte
n
So
m
et
i
m
es
/
N
ev
er
C
hi
-
sq
ua
re
p-
va
lu
e
A
ss
es
s h
om
e 
tr
ig
ge
rs
13
50
36
.4
 (3
.4)
46
.7
 (3
.6)
16
.9
 (2
.7)
40
.2
 (5
.7)
39
.4
 (5
.4)
20
.4
 (4
.5)
43
.7
 (4
.3 
)
38
.6
 (4
.3)
17
.7
 (3
.6)
38
.2
 (5
.0)
45
.3
 (4
.7)
16
.6
 (3
.8)
0.
74
A
ss
es
s s
ch
oo
l o
r 
w
o
rk
pl
ac
e 
tri
gg
er
s
13
55
33
.1
 (3
.2)
41
.2
 (3
.5)
25
.7
 (3
.2)
45
.3
 (5
.7)
33
.6
 (5
.1)
21
.1
 (4
.5)
29
.6
 (3
.7)
38
.5
 (4
.2)
32
.0
 (4
.0)
24
.6
 (4
.0)
46
.4
 (4
.5)
29
.0
 (4
.6)
0.
08
Te
st
 fo
r a
lle
rg
ic
 
se
n
sit
iv
ity
13
39
5.
5 
(1.
5)
15
.2
 (2
.8)
79
.3
 (3
.0)
10
.7
†  (
4.2
)
16
.0
 (4
.0)
73
.4
 (5
.2)
5.
6†
 
(1.
8)
26
.0
 (3
.9)
68
.4
 (4
.1)
3.
1†
 
(1.
6)
11
.9
 (3
.4)
85
.0
 (3
.6)
0.
12
† R
el
at
iv
e 
st
an
da
rd
 e
rro
r >
30
%
N
ot
es
: A
dh
er
en
ce
 c
at
eg
or
ie
s: 
A
lm
os
t a
lw
ay
s (
≥7
5%
 of
 th
e t
im
e),
 O
fte
n (
25
-<
75
%)
, S
om
eti
me
s/N
ev
er
 (<
25
%)
So
ur
ce
: N
at
io
na
l C
en
te
r f
or
 H
ea
lth
 S
ta
tis
tic
s, 
20
12
 N
at
io
na
l A
sth
m
a 
Su
rv
ey
 o
f P
hy
sic
ia
ns
: N
at
io
na
l A
m
bu
la
to
ry
 M
ed
ic
al
 C
ar
e 
Su
rv
ey
J Asthma. Author manuscript; available in PMC 2020 September 01.
